Esperion Therapeutics (NasdaqGM:ESPR) 2026 Extraordinary General Meeting July 08, 2026 08:00 AM ET Speaker0 The exact and final vote count for each proposal will be reported in the current report on Form 8-K, which will be filed with the U.S. Securities and Exchange Commission within four business days of today's meeting. Since there are no other matters to come before the meeting, this meeting shall now be adjourned. Thank you for your attendance. This now concludes the meeting. Thank you for joining, and ...